Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity - van Ryn, Joanne; Stangier, Joachim; Haertter, Sebastian; Liesenfeld, Karl-Heinz; Wienen, Wolfgang; Feuring, Martin; Clemens, Andreas (Thrombosis and haemostasis, 2010)
Keywords: Administration, Oral; Anticoagulants - administration & dosage; Anticoagulants - adverse effects; Anticoagulants - pharmacology; Benzimidazoles - administration & dosage; Benzimidazoles - adverse effects; Benzimidazoles - pharmacology; Blood Coagulation - drug effects; Cerebral Hemorrhage; Charcoal - therapeutic use; Dabigatran; Drug Overdose - drug therapy; Drug Overdose - etiology; Humans; International Normalized Ratio; Pyridines - administration & dosage; Pyridines - adverse effects; Pyridines - pharmacology; Sensitivity and Specificity; Thrombin - antagonists & inhibitors; Thrombin Time; Treatment Outcome; Venous Thromboembolism - diagnosis; Venous Thromboembolism - drug therapy; Venous Thromboembolism - physiopathology